Home >> News >> Business >> Global Peripheral Neuropathy market report just published by Credence Research Inc.

Global Peripheral Neuropathy market report just published by Credence Research Inc.

Global peripheral neuropathy market was valued at US$ 1,470.9s Mn in 2016, and is expected to reach US$ 1,998.8 Mn by 2025, expanding at a CAGR of 3.2% from 2017 to 2025.

The purpose of the report is to illustrate the state of the market of Peripheral Neuropathy, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2026.

Peripheral neuropathy mainly causes due to damage occurred to peripheral nerves resulting in weakness, numbness, and usually in hands and feet. Peripheral neuropathy is caused due to traumatic injuries, infections, metabolic problems, inherited causes and exposure to toxins, and most commonly by diabetes mellitus. According to the World Health Organization (WHO), it was estimated that there would be 285 million diabetics by 2010 in the world. This estimate is projected to increase by 65% to become 438 million in the year 2030. Thus, rising prevalence of diabetes mellitus is expected to increase the population of patients suffering from peripheral neuropathy. With a limited number of prescription drugs available for neuropathic pain, off-label prescription of several other drugs is widespread. The pharma industry has been struggling to further improve the currently available therapeutic options due to the complexity of identification of the most suitable targets for investigation. Recently, there has been a shift towards the adoption of transdermal therapies for the management of neuropathic pain.

Browse here for full report with Toc: https://www.credenceresearch.com/report/peripheral-neuropathy-market

The global peripheral neuropathy market is segmented by treatment type as pharmacological therapies and non-pharmacological therapies. Pharmacological therapies includes pain killers, anti-seizures medication, antidepressants. Non pharmacological therapies include transcutaneous electrical nerve stimulation, plasma exchange and intravenous immune globulin and others (physical therapy and surgery). Pharmacological therapies most commonly used and dominates the peripheral neuropathy market, while non-pharmacological therapies are used along with other treatment options.

Why was the report written?

This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Peripheral Neuropathy buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.

[The report is originally published on Credence Research Inc.]

What is the current market landscape and what is changing?

Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.

The report on the market of Peripheral Neuropathy contains:

Analysis and forecast of Peripheral Neuropathy market dynamics;

Analysis of domestic production, market shares of the main market players;

Analysis of exports and imports;

Analysis of factors, leading the development of the Peripheral Neuropathy market;

Assessment and forecast of Peripheral Neuropathy market development;

Financial and business profiles of the leading companies in the Peripheral Neuropathy industry.

Scope

– Up to date working Peripheral Neuropathy data by major regions in the world, the forecast of planned capacity additions by 2026

– The annual breakdown of capital expenditure spending on proposed Peripheral Neuropathy for the period 2018 to 2026

– Planned Peripheral Neuropathy additions and capital expenditure spending by key countries and companies across the world

– Planned capital expenditure spending on new Peripheral Neuropathy projects by region, key countries, and companies

– Details of major planned Peripheral Neuropathy projects in the world up to 2026

Browse here for full report with Toc: https://www.credenceresearch.com/report/peripheral-neuropathy-market

Also you can request us for sample in pdf with more details and graph: https://www.credenceresearch.com/sample-request/58475

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact Us:

Credence Research Inc.

105 N 1st ST #429

SAN JOSE

CA 95103

United States

Toll Free (US/CANADA): +1-800-361-8290

Web: https://www.credenceresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *